BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11759065)

  • 1. Three-dimensional imaging of hormone-secreting cells and their microvessel environment in estrogen-induced prolactinoma of the rat pituitary gland by confocal laser scanning microscopy.
    Itoh J; Kawai K; Serizawa A; Yamamoto Y; Ogawa K; Matsuno A; Watanabe K; Osamura RY
    Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):364-70. PubMed ID: 11759065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular networks and endothelial cells in the rat experimental pituitary glands and in the human pituitary adenomas.
    Itoh J; Serizawa A; Kawai K; Ishii Y; Teramoto A; Osamura RY
    Microsc Res Tech; 2003 Feb; 60(2):231-5. PubMed ID: 12539177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach to three-dimensional reconstructed imaging of hormone-secreting cells and their microvessel environments in rat pituitary glands by confocal laser scanning microscopy.
    Itoh J; Kawai K; Serizawa A; Yasumura K; Ogawa K; Osamura RY
    J Histochem Cytochem; 2000 Apr; 48(4):569-78. PubMed ID: 10727298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary Hyperplasia, Hormonal Changes and Prolactinoma Development in Males Exposed to Estrogens-An Insight From Translational Studies.
    Šošić-Jurjević B; Ajdžanović V; Miljić D; Trifunović S; Filipović B; Stanković S; Bolevich S; Jakovljević V; Milošević V
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bromocriptine and terguride on cell proliferation and apoptosis in the estrogen-stimulated anterior pituitary gland of the rat.
    Yonezawa K; Tamaki N; Kokunai T
    Neurol Med Chir (Tokyo); 1997 Dec; 37(12):901-6. PubMed ID: 9465588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the ultrastructural distribution of prolactin and growth hormone mRNAs in pituitary cells of female rats after estrogen and bromocriptine treatment, studied using in situ hybridization with biotinylated oligonucleotide probes.
    Matsuno A; Ohsugi Y; Utsunomiya H; Takekoshi S; Sanno N; Osamura RY; Watanabe K; Teramoto A; Kirino T
    Histochem Cell Biol; 1995 Jul; 104(1):37-45. PubMed ID: 7584558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terguride as a new anti-hyperprolactinemic agent: characterization in rats and dogs in comparison with bromocriptine.
    Mizokawa T; Akai T; Nakada Y; Yamaguchi M; Nakagawa H; Hasan S; Rettig KJ; Wachtel H
    Jpn J Pharmacol; 1993 Nov; 63(3):269-78. PubMed ID: 7906316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone secretion by cell culture of human GH-PRL secreting pituitary adenomas: effects of bromocriptine.
    Lei T; Bai X; Liu K; Hu W; Xue D; Jiang X
    J Tongji Med Univ; 1998; 18(3):161-3. PubMed ID: 10806816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of bromocriptine on estrogen-induced rat prolactinoma].
    Otsuka R
    Neurol Med Chir (Tokyo); 1987 Jun; 27(6):475-81. PubMed ID: 2448665
    [No Abstract]   [Full Text] [Related]  

  • 10. [Morphological studies on estrogen-induced PRL cell hyperplasia in rat pituitary gland--immunocytochemical and scanning electron microscopic studies].
    Inagaki H; Hori T
    No To Shinkei; 1989 Jun; 41(6):593-601. PubMed ID: 2803826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural localization of prolactin in estrogen-induced prolactinoma of the rat pituitary. Experimental models for the human prolactinomas and the effects of bromocriptine.
    Osamura RY; Watanabe K
    Acta Pathol Jpn; 1986 Aug; 36(8):1131-7. PubMed ID: 3776530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of a long-acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas.
    Tsagarakis S; Tsiganou E; Tzavara I; Nikolou H; Thalassinos N
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):593-9. PubMed ID: 7634499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of octreotide and bromocriptine on expression of a pro-apoptotic Bax protein in rat prolactinoma.
    Gruszka A; Kunert-Radek J; Pawlikowski M
    Folia Histochem Cytobiol; 2004; 42(1):35-9. PubMed ID: 15046398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of lactogenic receptors. II. Studies on the liver of hypophysectomized male rats and on rats bearing a growth hormone secreting tumor.
    Aragona C; Bohnet HG; Fang VS; Friesen HG
    Endocr Res Commun; 1976; 3(3-4):199-208. PubMed ID: 183948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas.
    Xiao Z; Yang X; Zhang K; Liu Z; Shao Z; Song C; Wang X; Li Z
    Int J Med Sci; 2020; 17(18):3174-3189. PubMed ID: 33173437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tamoxifen on serum prolactin levels, pituitary immunoreactive prolactin cells and uterine growth in estradiol-treated ovariectomized rats.
    Spritzer PM; Ribeiro MF; Oliveira MC; Barbosa-Coutinho LM; Silva IS; Dahlem N; Cericatto R; Pavanato MA
    Horm Metab Res; 1996 Apr; 28(4):171-6. PubMed ID: 8740191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of confocal laser scanning microscopy (CLSM) to visualize prolactin (PRL) and PRL mRNA in the normal and estrogen-treated rat pituitary glands using non-fluorescent probes.
    Itoh J; Sanno N; Matsuno A; Itoh Y; Watanabe K; Osamura RY
    Microsc Res Tech; 1997 Oct; 39(2):157-67. PubMed ID: 9361267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tamoxifen on GH and PRL secretion by human pituitary tumors.
    Lamberts SW; de Quijada M; Klijn JG
    J Endocrinol Invest; 1980; 3(4):343-7. PubMed ID: 7204884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased prolactin level in secretory granules and their increased exocytosis in estrogen-induced pituitary hyperplasia in rats treated with a dopamine agonist.
    Maeda T; Sawada K; Itoh Y; Moriwaki K; Mori H
    Lab Invest; 1991 Dec; 65(6):679-87. PubMed ID: 1753713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of hypokalaemia on the hormone exocytosis in adenohypophysis and prolactinoma cell culture model systems.
    Molnár Z; Pálföldi R; László A; Radács M; László M; Hausinger P; Tiszlavicz L; Rázga Z; Valkusz Z; Gálfi M
    Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):575-81. PubMed ID: 25054312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.